Adaptive Biotechnologies (ADPT) Shares Outstanding (2018 - 2026)

Adaptive Biotechnologies has disclosed Shares Outstanding (Entity) across 9 years of filings, most recently posting $159.1 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 4.48% year-over-year to $159.1 million; the TTM figure through Jun 2026 stood at $159.1 million (up 4.48% YoY), while the FY2025 annual figure was $153.8 million, up 4.06% from the prior year.
• Shares Outstanding (Entity) came in at $159.1 million for Q2 2026 at Adaptive Biotechnologies, roughly flat from $159.7 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $159.7 million in Q1 2026 to a low of $142.2 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $148.3 million, with a median of $147.4 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) increased 1.21% in 2022 and increased 5.12% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $143.1 million in 2022, then gained by 1.38% to $145.1 million in 2023, then advanced by 1.86% to $147.8 million in 2024, then gained by 4.06% to $153.8 million in 2025, then grew by 3.43% to $159.1 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $159.1 million in Q2 2026, $159.7 million in Q1 2026, and $153.8 million in Q4 2025.